TIDMGWP

RNS Number : 2854N

GW Pharmaceuticals PLC

28 January 2016

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                                           GW PHARMACEUTICALS PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
---------------------------------------------------------------  ------------------------------------ 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
----------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                                        X 
------------------------------------------------------------------  --------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------------  --------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------------  --------------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------  --------------------------------- 
 Other (please 
  specify): 
---------------------------------------------------------  -------  --------------------------------- 
 3. Full name of person(s)                                          The Bank of New York Mellon 
  subject to the                                                            Corporation 
  notification obligation: 
  (iii) 
-----------------------------------------------------------  ---------------------------------------- 
 4. Full name of shareholder(s)                                    The Bank of New York Mellon; 
  (if different from 3.):(iv)                                       The Dreyfus Corporation; The 
                                                                  Boston Company Asset Management 
                                                                     LLC; BNY Mellon, National 
                                                                  Association; BNY Mellon Capital 
                                                                           Markets, LLC. 
-----------------------------------------------------------  ---------------------------------------- 
 5. Date of the transaction                                               26 January 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  ---------------------------------------- 
 6. Date on which issuer                                                  27 January 2016 
  notified: 
-----------------------------------------------------------  ---------------------------------------- 
 7. Threshold(s) that is/are                                             Crossing above 5% 
  crossed or 
  reached: (vi, vii) 
-----------------------------------------------------------  ---------------------------------------- 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------------------------ 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------------------------------ 
 Class/type     Situation previous                 Resulting situation after the 
  of             to the triggering                  triggering transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  ---------------------------------  ---------------------------------------------------------------------- 
                Number           Number            Number         Number of                    % of voting 
                 of               of                of shares      voting                       rights (x) 
                 Shares           Voting                           rights 
                                  Rights 
-------------  ---------------  ----------------  -------------  ---------------------------  -------------------------- 
                                                   Direct         Direct          Indirect     Direct         Indirect 
                                                                   (xi)            (xii) 
-------------      -----------    ------------    -------------  --------------  -----------  -------------  ----------- 
 Common Stock   11,862           11,862            11,862         11,862          N/A          0.0045%        N/A 
 GB0030544687 
 
 
 ADR            1,076,351         12,916,212        1,165,618     13,987,416       N/A         5.3270%         N/A 
               ---------------  ----------------  -------------  --------------  -----------  -------------  ----------- 
 US36197T1034 
-------------      -----------    ------------      -----------    ------------  -----------      ---------    --------- 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------ 
 Type of            Expiration     Exercise/                        Number of voting               % of voting 
 financial           date           Conversion                       rights that                    rights 
 instrument          (xiii)         Period (xiv)                     may be 
                                                                     acquired if 
                                                                     the 
                                                                     instrument 
                                                                     is 
                                                                     exercised/ 
                                                                     converted. 
-----------------  -------------  -------------------------------  -----------------------------  ---------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------ 
 Type of          Exercise       Expiration      Exercise/        Number of voting               % of voting 
 financial         price         date            Conversion        rights instrument              rights (xix, 
 instrument                      (xvii)          period            refers to                      xx) 
                                                 (xviii) 
---------------  -------------  --------------  ---------------  -----------------------------  ------------------------ 
                                                                                                 Nominal        Delta 
---------------  -------------  --------------  ---------------  -----------------------------  -------------  --------- 
 
 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------------------ 
 Number of voting rights                             Percentage of voting rights 
--------------------------------------------------  -------------------------------------------------------------------- 
 13,999,278                                          5.33% 
--------------------------------------------------  -------------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
---------------------------------------------------------------------------- 
 
   The Bank of New York Mellon Corporation is making this 
   disclosure as the ultimate parent company of: The Bank 
   of New York Mellon; The Dreyfus Corporation; The Boston 
   Company Asset Management LLC; BNY Mellon, National Association 
   and BNY Mellon Capital Markets, LLC. 
 
 Proxy Voting: 
---------------------------------------------------------------------------- 
 10. Name of the proxy holder:                                      N/A 
------------------------------------------------------------  -------------- 
 11. Number of voting rights proxy                                  N/A 
  holder will cease 
  to hold: 
------------------------------------------------------------  -------------- 
 12. Date on which proxy holder will                                N/A 
  cease to hold 
  voting rights: 
------------------------------------------------------------  -------------- 
 
 
  13. Additional information:                                       N/A 
------------------------------------------------------------  -------------- 
 14. Contact name:                                             Andrew Weiser 
------------------------------------------------------------  -------------- 
 15. Contact telephone number:                                 516-338-3752 
------------------------------------------------------------  --------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAPFPALKKEEF

(END) Dow Jones Newswires

January 28, 2016 03:47 ET (08:47 GMT)

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.